- Home
- JNJ
as 07-01-2025 3:38pm EST
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
| Founded: | 1886 | Country: | United States |
| Employees: | N/A | City: | NEW BRUNSWICK |
| Market Cap: | 373.9B | IPO Year: | 1944 |
| Target Price: | $169.33 | AVG Volume (30 days): | 7.9M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.98 | EPS Growth: | -41.22 |
| 52 Week Low/High: | $140.68 - $169.99 | Next Earning Date: | 07-16-2025 |
| Revenue: | $89,331,000,000 | Revenue Growth: | 4.30% |
| Revenue Growth (this year): | 3.87% | Revenue Growth (next year): | 4.14% |
Latest Johnson & Johnson News
JNJ Breaking Stock News: Dive into JNJ Ticker-Specific Updates for Smart Investing
Zacks
16 hours ago
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
Zacks
16 hours ago
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Zacks
16 hours ago
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
PR Newswire
a day ago
PJM Appoints Deena O'Brien as Senior Director of Communications
Business Wire
2 days ago
The Hackett Group® Announces Winners of the 2025 Hackett Innovation Awards
CNW Group
2 days ago
Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
Insider Monkey
4 days ago
Johnson & Johnson’s (JNJ) IMAAVY Demonstrates Superior gMG Control
Barchart
5 days ago
Here's What to Expect From Johnson & Johnson's Next Earnings Report
Compare JNJ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JNJ Johnson & Johnson - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.